Cargando…
Cyclosporine as Therapy for Traumatic Brain Injury
Drug development in traumatic brain injury (TBI) has been impeded by the complexity and heterogeneity of the disease pathology, as well as limited understanding of the secondary injury cascade that follows the initial trauma. As a result, patients with TBI have an unmet need for effective pharmacolo...
Autores principales: | Hansson, Magnus J., Elmér, Eskil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684836/ https://www.ncbi.nlm.nih.gov/pubmed/37561274 http://dx.doi.org/10.1007/s13311-023-01414-z |
Ejemplares similares
-
Neuroprotective Effects of Cyclosporine in a Porcine Pre-Clinical Trial of Focal Traumatic Brain Injury
por: Karlsson, Michael, et al.
Publicado: (2019) -
The efficacy of Cyclosporine-A on Diffuse Axonal Injury after Traumatic Brain Injury
por: Aminmansour, Bahram, et al.
Publicado: (2014) -
Copenhagen Head Injury Ciclosporin Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury Patients
por: Kelsen, Jesper, et al.
Publicado: (2019) -
Brain injury following cardiac arrest: pathophysiology for neurocritical care
por: Uchino, Hiroyuki, et al.
Publicado: (2016) -
Patients with sepsis exhibit increased mitochondrial respiratory capacity in peripheral blood immune cells
por: Sjövall, Fredrik, et al.
Publicado: (2013)